Company Filing History:
1 out of 2 
1 out of 1,744 
Years Active: 2018
Title: Discovering Kamalakannan Velmurugan: Innovator in Recombinant Technologies
Introduction
Kamalakannan Velmurugan, based in Rockville, MD, is an innovative inventor recognized for his contributions to recombinant technologies. He has successfully developed a patent that showcases his expertise in biotechnology, particularly in the realm of mycobacterial research.
Latest Patents
Velmurugan holds a significant patent titled "Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion protein and uses thereof." This invention involves recombinant mycobacterium (rMyc) that encodes the heparin-binding hemagglutinin fusion protein, which includes an amino terminal mycobacterial antigen Ag85B leader peptide. Moreover, the transcription is driven by an Ag85B promoter sequence, leading to the abundant production of the recombinant fusion protein, which is post-translationally methylated and highly antigenic.
Career Highlights
Throughout his career, Kamalakannan Velmurugan has amassed valuable experience in renowned research organizations. Notably, he has worked with Aeras, a global nonprofit organization dedicated to the discovery and development of vaccines for tuberculosis and other infectious diseases. Additionally, he has contributed to projects at the Institut National de la Santé et de la Recherche Médicale, highlighting his commitment to noteworthy healthcare advancements.
Collaborations
Velmurugan has collaborated with distinguished coworkers, including John Fulkerson and Michael Brennan. Their collective efforts in the field of recombinant proteins have significantly advanced understanding and applications in medical research.
Conclusion
Kamalakannan Velmurugan's innovative spirit and his groundbreaking work in recombinant technologies are commendable. His patent on the recombinant mycobacterium with heparin-binding hemagglutinin fusion protein exemplifies his dedication to advancing the field of biotechnology. As he continues to collaborate with other researchers, Velmurugan is poised to make further impactful contributions to healthcare and scientific research.